<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01688219</url>
  </required_header>
  <id_info>
    <org_study_id>45896566645469</org_study_id>
    <nct_id>NCT01688219</nct_id>
  </id_info>
  <brief_title>Immune Response in the SAPHO Syndrome</brief_title>
  <official_title>Immune Mechanisms During SAPHO Syndrome and Treatment by Etarnecept</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <brief_summary>
    <textblock>
      The aetiology of SAPHO syndrome seems to involve genetic, infectious and immunological
      components. The investigators examined innate and adaptative immune responses in SAPHO
      syndrome as compared with psoriatic arthritis and rheumatoid arthritis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IL-8 production by PMN</measure>
    <time_frame>24 h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>TNFalpha production by PMN</measure>
    <time_frame>24 h</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">39</enrollment>
  <condition>SAPHO Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        SAPHO syndrome patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of SAPHO syndrome

          -  Must have bone lesions

        Exclusion Criteria:

          -  Infliximab treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilles Hayem, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Assitance Publique-Hopitaux Paris</affiliation>
  </overall_official>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2012</study_first_submitted>
  <study_first_submitted_qc>September 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2012</study_first_posted>
  <last_update_submitted>September 18, 2012</last_update_submitted>
  <last_update_submitted_qc>September 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SAPHO syndrome</keyword>
  <keyword>Innate immunity</keyword>
  <keyword>TNF alpha</keyword>
  <keyword>Polymorphonuclear neutrophils</keyword>
  <keyword>Propionibacterium acnes</keyword>
  <keyword>Interleukin-8</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Acquired Hyperostosis Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

